Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2024-12-12 DOI:10.3324/haematol.2024.286534

Shuangyou Liu, Lihong An, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Biping Deng, Xinjian Yu, Qinlong Zheng, Defeng Zhao, Tong Wu, Alex H Chang, Chunrong Tong

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

CD19和CD22嵌合抗原受体t细胞治疗b细胞急性淋巴细胞白血病患者在同种异体移植后复发的5年预后

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.